Federal Circuit Prescribes a Treatment for § 101 Disorder
July, 3rd, 2018
Categories: Articles, Blog Tags: 101, CAFC, patent, USPTO, whipgroup
The Federal Circuit recently provided insight into the complicated issue of § 101 subject matter eligibility for method of treatment claims. In Vanda Pharmaceuticals Inc v West-Ward Pharmaceuticals, 887 F.3d. 1117 (Fed. Cir. 2018), a [Read More…]